Case Control Study
Copyright ©The Author(s) 2024.
World J Psychiatry. Dec 19, 2024; 14(12): 1804-1814
Published online Dec 19, 2024. doi: 10.5498/wjp.v14.i12.1804
Table 1 Comparison of clinical data and serum inflammatory cytokines and brain derived neurotrophic factor between the schizophrenia and healthy controls groups
Variable
SCZ group (84 cases)
HCs group (80 cases)
χ2/t value
P value
Sex, n (%)0.2160.642
    Male40 (48)41 (51)
    Female44 (52)49 (49)
Age (years, mean ± SD)39.09 ± 10.2440.35 ± 11.110.2240.815
Education years (years, mean ± SD)13.41 ± 3.3514.54 ± 4.021.1210.262
Smoking history, n (%)0.0810.776
    Yes28 (30)25 (31)
    No56 (70)55 (69)
Duration of illness (months, mean ± SD)9.75 ± 3.42NANANA
PANSS score (points, mean ± SD)
    Positive symptom score24.63 ± 1.71NANANA
    Negative symptom score20.05 ± 2.09NANANA
    General pathology score41.77 ± 2.06NANANA
    Total score80.05 ± 4.28NANANA
C-BCT cognitive function assessment scores for various dimensions (points, mean ± SD)
    Information processing speed32.95 ± 5.12a47.58 ± 5.6917.313< 0.001
    Attention31.17 ± 7.47a41.55 ± 7.7612.073< 0.001
    Working memory 35.01 ± 7.18a47.071 ± 1.168.271< 0.001
    Comprehensive + execution ability32.31 ± 9.89a47.30 ± 7.4812.395< 0.001
Levels of serum inflammatory factors and BDNF (pg/mL, mean ± SD)
    IL-1β37.08 ± 5.11a26.95 ± 3.5414.579< 0.001
    IL-430.85 ± 7.5929.35 ± 4.131.5580.121
    IL-641.15 ± 5.92a29.37 ± 7.5811.104< 0.001
    IL-1028.76 ± 9.5126.43 ± 6.581.6900.093
    BDNF1383.98 ± 315.33a2692.42 ± 301.0317.711< 0.001